Expert opinion on managing chronic HCV in patients with neuropsychiatric manifestations. (Record no. 29066290)

MARC details
000 -LEADER
fixed length control field 01407 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518010624.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201909s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2040-2058
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3851/IMP3245
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Forton, Daniel
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190925
245 00 - TITLE STATEMENT
Title Expert opinion on managing chronic HCV in patients with neuropsychiatric manifestations.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Antiviral therapy
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent 47-55 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antiviral Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cognitive Dysfunction
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Depression
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Management
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fatigue
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepacivirus
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hepatitis C, Chronic
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neuroprotective Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nootropic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Parkinson Disease
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Practice Guidelines as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quality of Life
General subdivision psychology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weissenborn, Karin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bondin, Mark
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cacoub, Patrice
773 0# - HOST ITEM ENTRY
Title Antiviral therapy
Related parts vol. 23
-- no. Suppl 2
-- p. 47-55
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3851/IMP3245">https://doi.org/10.3851/IMP3245</a>
Public note Available from publisher's website

No items available.